Reuters logo
BRIEF-Pfizer receives FDA approval for MYLOTARG (gemtuzumab ozogamicin)
September 1, 2017 / 3:41 PM / 20 days ago

BRIEF-Pfizer receives FDA approval for MYLOTARG (gemtuzumab ozogamicin)

Sept 1 (Reuters) - Pfizer Inc:

* Pfizer receives FDA approval for MYLOTARG (gemtuzumab ozogamicin) Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below